MannKind Corporation to Participate in the Lytham Partners Investor Select Conference
January 24 2023 - 5:00AM
MannKind Corporation (Nasdaq: MNKD), a company
focused on the development and commercialization of inhaled
therapeutic products and devices for patients with endocrine and
orphan lung diseases, announced today that its Chief Executive
Officer, Michael Castagna, PharmD, and Chief Financial Officer,
Steven B. Binder, will participate in the Lytham Partners Investor
Select Conference taking place virtually on Tuesday, January 31,
2023.
The Company’s webcast presentation will be available for viewing
at 9:00am ET on Tuesday, January 31, 2023, on the Company's website
at Events & Presentations or
https://investors.mannkindcorp.com/events-and-presentations. The
webcast will also be archived and available for replay.
Management will be participating in virtual one-on-one meetings.
To arrange a meeting with management, please contact Lytham
Partners at 1x1@lythampartners.com.
About MannKindMannKind Corporation (Nasdaq:
MNKD) focuses on the development and commercialization of
innovative therapeutic products and devices to address serious
unmet medical needs for those living with endocrine and orphan lung
diseases.
We are committed to using our formulation capabilities and
device engineering prowess to lessen the burden of diseases such as
diabetes, pulmonary arterial hypertension (PAH) and nontuberculous
mycobacterial (NTM) lung disease. Our signature technologies –
dry-powder formulations and inhalation devices – offer rapid and
convenient delivery of medicines to the deep lung where they can
exert an effect locally or enter the systemic circulation.
With a passionate team of Mannitarians collaborating nationwide,
we are on a mission to give people control of their health and the
freedom to live life.
Please visit mannkindcorp.com to learn more, and follow us on
LinkedIn, Facebook, Twitter or Instagram.
MannKind Contact:Rose Alinaya,
Investor Relations(818) 661-5000Email: ir@mannkindcorp.com
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Jun 2024 to Jul 2024
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Jul 2023 to Jul 2024